|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.210 USD | -0.96% |
|
-15.90% | -29.54% |
| 05-07 | Vanda Pharmaceuticals Inc., Q1 2026 Earnings Call, May 06, 2026 | |
| 05-06 | Vanda Pharmaceuticals Inc. Raises Revenue Guidance for the Full-Year 2026 | CI |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.96% | -15.90% | -13.20% | +1.55% | -29.54% | +54.22% | -1.04% | -65.08% | -24.48% | 377M | |
| +1.01% | +2.89% | +3.13% | -0.68% | -2.59% | +40.00% | +88.60% | +234.39% | +6,051.54% | 50.65B | |
| +1.48% | +0.71% | +3.76% | +8.02% | +21.72% | +86.81% | +62.75% | -11.72% | - | 48.58B | |
| +0.13% | -2.25% | -3.46% | -11.73% | -1.94% | -4.03% | -11.30% | -49.85% | - | 23.6B | |
| +7.13% | -20.13% | -26.32% | -23.81% | -36.01% | +64.38% | +494.58% | +320.88% | +938.85% | 22.52B | |
| +1.94% | -2.49% | -6.13% | -18.60% | +7.19% | +45.89% | -27.68% | -67.47% | - | 17.47B | |
| +3.22% | -1.35% | -4.62% | -8.96% | -15.52% | +29.73% | -40.31% | -23.24% | +70.74% | 16.06B | |
| -0.99% | +1.72% | -5.93% | +23.57% | +15.04% | +54.12% | +196.47% | +162.89% | - | 15.45B | |
| -1.07% | +5.33% | -7.76% | +26.28% | +5.63% | -26.86% | +974.13% | +237.75% | +125.08% | 14.48B | |
| +2.58% | -0.04% | -6.53% | +5.21% | +17.49% | +43.55% | - | - | - | 13.38B | |
| -0.93% | +11.64% | +10.30% | +16.14% | +13.14% | +34.10% | +158.55% | +97.10% | +855.49% | 12.49B | |
| +0.53% | -0.58% | -4.97% | +5.44% | -14.22% | +66.10% | +70.54% | +276.43% | - | 11.46B | |
| +0.65% | +4.55% | +22.81% | +25.59% | +18.00% | +460.77% | +99.24% | +14.03% | +1,369.79% | 10.95B | |
| -0.42% | +12.88% | +14.69% | +11.62% | +17.34% | +135.24% | +97.09% | +213.67% | +879.76% | 9.28B | |
| -3.51% | -3.31% | -10.47% | +16.23% | +31.81% | +153.40% | +135.78% | +7.23% | - | 9.09B | |
| +0.97% | -1.70% | -4.94% | -15.45% | -30.01% | - | - | - | - | 8.72B | |
| -0.74% | +5.41% | +9.45% | +20.69% | +303.54% | +238.56% | +250.44% | -47.40% | - | 8.49B | |
| +0.71% | +10.23% | +10.06% | -1.93% | +51.28% | +53.21% | +126.08% | +885.04% | +381.17% | 8.35B | |
| -1.86% | +1.43% | -0.74% | +1.57% | +2.32% | +39.78% | +161.22% | - | - | 8.26B | |
| -0.58% | -3.54% | -13.09% | -2.33% | +16.32% | +69.90% | +8.47% | +187.47% | - | 7.8B | |
| Average | +0.46% | -1.19% | -1.70% | +3.92% | +19.55% | +86.26% | +157.98% | +139.54% | +1,183.10% | 15.87B | |
| Weighted average by Cap. | +1.04% | -1.19% | -1.37% | +2.23% | +12.66% | +71.74% | +152.38% | +128.07% | +2,532.61% |
- Stock Market
- Equities
- VNDA Stock
- Sector Vanda Pharmaceuticals Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition